Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07442461 · ClinicalTrials.gov registry record · NA

Virtual Assistance for Daily Living: Neurophysiological and Functional Effects in Low Vision

A NA study, sponsored by NYU Langone Health.

Not yet
Registry status
NA
Development phase
150
Enrollment target

NCT07442461 is a NA study that has not yet begun recruiting, run by NYU Langone Health. The registered enrollment target is 150 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07442461, a NA study, has not yet begun recruiting, sponsored by NYU Langone Health.

NOT YET RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

This study aims to investigate how visual impairment affects neurophysiological and biomechanical responses during real-world navigation and daily activities, with a focus on the rehabilitative feasibility and impact of assistive technologies. These technologies include applications and wearable devices designed to support various aspects of daily living for individuals with visual impairment. The VIS4ION platform (Visually Impaired Smart Service System for Spatial Intelligence \& On-board Navigation), a wearable system providing tactile and auditory feedback, is one component of this broader study. VIS4ION is designed to enhance environmental awareness and reduce cognitive load during mobility tasks for the visually impaired.

Interventions

  • DEVICE VIS4ION Platform

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2026-03-01
Est. Completion 2028-12-30
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT07442461

The ClinicalTrials.gov registry entry for NCT07442461 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which VIS4ION Platform is the first listed.

NCT07442461 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07442461 about?

NCT07442461 is a clinical study titled "Virtual Assistance for Daily Living: Neurophysiological and Functional Effects in Low Vision". This study aims to investigate how visual impairment affects neurophysiological and biomechanical responses during real-world navigation and daily activities, with a focus on the rehabilitative feasibility and impact of assistive technologies. These technologies include applications and wearable dev...

What is the current status of trial NCT07442461?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2026-03-01. Estimated completion is 2028-12-30.

What interventions are being tested in trial NCT07442461?

The interventions under investigation include: VIS4ION Platform (DEVICE).

Who is sponsoring clinical trial NCT07442461?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.